Stockscreener 앱 받기
6.92
1.91%
0.13
시간 외 거래:
6.90
-0.02
-0.29%
Ginkgo Bioworks Holdings Inc 주식(DNA)의 최신 뉴스
Ginkgo Bioworks (NYSE: DNA) insider plans 2,200-share sale - Stock Titan
How Ginkgo Bioworks Holdings Inc. Class A (DNA) Affects Rotational Strategy Timing - Stock Traders Daily
These Analysts Think Ginkgo Bioworks Holdings, Inc.'s (NYSE:DNA) Sales Are Under Threat - moomoo.com
Ginkgo Bioworks Holdings, Inc. (NYSE:DNA) Analysts Just Slashed This Year's Revenue Estimates By 22% - simplywall.st
Ginkgo Bioworks Holdings, Inc. (DNA) Q2 2026 Earnings ReportResults, Call & Slides - TipRanks
Ginkgo Bioworks (DNA) Short Interest & Short Float | Updated Aug 2026 $DNA - MarketBeat
William Blair Maintains Ginkgo Bioworks(DNA.US) With Sell Rating - Moomoo
Ginkgo Bioworks Holdings Inc (DNA) Earnings Forecast: Future EPS & Revenue Growth Estimates - tradingkey.com
Ginkgo Bioworks (DNA) Sheds 3.33% as Shares Approach Critical $6.9 SupportGrowth Factor - dars.gov.et
Kolchinsky Warns Ban on Chinese Biotech Deals Would Hand Pipeline to Novartis - finance.biggo.com
Ginkgo Bioworks Holdings Number of Employees 2026 | Employee Count & Headcount Data - Revelio Labs
Ginkgo Bioworks Holdings, Inc. (NYSE:DNA) Shares Slammed 36% But Getting In Cheap Might Be Difficult Regardless - 富途牛牛
Ginkgo Bioworks (NYSE:DNA) Stock Rating Upgraded by Wall Street Zen - MarketBeat
Ginkgo Bioworks Q2 Earnings Call Highlights - MarketBeat
DNA Downgraded by TD Cowen -- Price Target Lowered to $9.00 - GuruFocus
TD Cowen Downgrades Ginkgo Bioworks(DNA.US) to Hold Rating, Cuts Target Price to $9 - Moomoo
TD Cowen cuts Ginkgo Bioworks stock rating on growth uncertainty - Investing.com India
TD Cowen Downgrades Ginkgo Bioworks to Hold From Buy, Adjusts Price Target to $9 From $12 - marketscreener.com
TD Cowen cuts Ginkgo Bioworks stock rating on growth uncertainty By Investing.com - Investing.com Australia
TD Cowen Downgrades Ginkgo Bioworks Holdings Inc (DNA) to Hold - StreetInsider
Ginkgo Bioworks Holdings, Inc. Q2 2026 Earnings Call Summary - Yahoo Finance
Ginkgo Bioworks Holdings, Inc. reports results for the quarter ended June 30Earnings Summary - TradingView
Ginkgo Bioworks Holdings, Inc. 2Q 2026: Revenue ($46.95M), Net income ($46.71M), EPS ($0.75) — 10-Q Summary - TradingView
Biosecurity sale shapes Ginkgo Bioworks (NYSE: DNA) Q2 2026 results - Stock Titan
Ginkgo Bioworks Holdings, Inc. 2026 Q2ResultsEarnings Call Presentation (NYSE:DNA) 2026-08-06 - Seeking Alpha
Ginkgo Bioworks (NYSE:DNA) Trading Down 9.6%Here's What Happened - MarketBeat
Analysts’ Opinions Are Mixed on These Healthcare Stocks: Ginkgo Bioworks Holdings (DNA), Exelixis (EXEL) and Editas Medicine (EDIT) - The Globe and Mail
BlackRock, Inc. Buys Ginkgo Bioworks Holdings Inc (DNA) -- Shares Look 32% Overvalued on GF Value - GuruFocus
Earnings call transcript: Ginkgo Bioworks Q2 2026 revenue miss weighs on shares - Investing.com Canada
Ginkgo Bioworks : Q2 2026 Results Presentation - marketscreener.com
Ginkgo Bioworks (NYSE:DNA) Releases Earnings Results, Beats Expectations By $0.15 EPS - MarketBeat
Ginkgo Bioworks (DNA) Stock Falls on Q2 2026 Earnings - Quiver Quantitative
Ginkgo Bioworks Holdings, Inc. (DNA) Q2 FY2026 earnings call transcript - Yahoo Finance
Ginkgo Bioworks reports Q2 2026 revenue $20.2M, GAAP net loss $57.3M, Adjusted EBITDA ($36.3M) - TradingView
Ginkgo Bioworks (NYSE: DNA) posts Q2 loss, wins $47M lab deal - Stock Titan
(DNA) and the Role of Price-Sensitive Allocations - Stock Traders Daily
Ginkgo Bioworks earnings beat by $0.13, revenue fell short of estimates - Investing.com Canada
Ginkgo Bioworks partners with Acies Bio to license Aspergillus niger strains for protein production - Bitget
Ginkgo Bioworks Holdings Inc (DNA) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Ginkgo Bioworks (DNA.US) will release its earnings report after market close on August 5. - Moomoo
Ginkgo Bioworks (DNA) CEO Jason R. Kelly receives over 300k new RSUs - Stock Titan
Ginkgo Bioworks (NYSE: DNA) plans Q2 2026 results presentation and Q&A - Stock Titan
Ginkgo Bioworks (DNA) to Release Earnings on Thursday - MarketBeat
Ginkgo Bioworks Holdings Inc (DNA) Balance Sheet - TradingKey
Ginkgo Bioworks Holdings Inc (DNA) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
DNA|Ginkgo Bioworks Holdings Inc|Price:7.445|Chg%:+0.085 - TradingKey
Ginkgo Bioworks Holdings Inc (DNA) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Ginkgo Bioworks Holdings Inc (DNA) Income Statement - TradingKey
DNA|Ginkgo Bioworks Holdings Inc|Price:7.761| - TradingKey
ETFs Investing in Ginkgo Bioworks Holdings, Inc. Class A Stocks - TradingView
Ginkgo Bioworks Holdings Inc (DNA) Cash Flow - TradingKey
Ginkgo Bioworks Holdings Inc (DNA) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Ginkgo Bioworks Holdings Inc (DNA) Valuation: PE, PB & Fair Value Analysis - TradingKey
Ginkgo Bioworks Holdings Inc - tradingkey.com
DNA|Ginkgo Bioworks Holdings Inc|Price:7.360|Chg%:-0.575 - TradingKey
Ginkgo Bioworks Holdings, Inc. Revenue Breakdown – NYSE:DNA - TradingView
Responsive Playbooks and the DNA Inflection - Stock Traders Daily
Ginkgo Regains Compliance with NYSE Minimum Bid Price Requiremen - GuruFocus
Ginkgo Bioworks Holdings Inc (DNA) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Ginkgo CEO Jason Kelly: Block U.S. Investment in Chinese Biotech Before Drug Discovery Moves Entirely Offshore - finance.biggo.com
GINKGO BIOWORKS HOLDINGS, INC. F/K/A SOARING EAGLE ACQUISITION CORP. (DNA, SRNG) SHAREHOLDER CLASS ACTION ALERT: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Acti - TMX Newsfile
Biotech firm Ginkgo in talks with SPAC for over $20b deal - The Financial Express
Ginkgo Bioworks (NYSE: DNA) CFO logs RSU vesting and tax sell-to-cover - Stock Titan
1.80%
1.77%
자본화:
|
볼륨(24시간):